Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.

Klistorner A, Garrick R, Barnett MH, Graham SL, Arvind H, Sriram P, Yiannikas C.

Neurology. 2013 Jan 15;80(3):242-5. doi: 10.1212/WNL.0b013e31827deb39. Epub 2012 Dec 26.

PMID:
23269599
2.

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Galetta KM, Calabresi PA, Frohman EM, Balcer LJ.

Neurotherapeutics. 2011 Jan;8(1):117-32. doi: 10.1007/s13311-010-0005-1. Review.

3.

Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2011 Dec;31(4):362-73. doi: 10.1097/WNO.0b013e318238937f. Review.

4.

Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Kolappan M, Henderson AP, Jenkins TM, Wheeler-Kingshott CA, Plant GT, Thompson AJ, Miller DH.

J Neurol. 2009 Mar;256(3):305-19. doi: 10.1007/s00415-009-0123-z. Epub 2009 Mar 18. Review.

PMID:
19296047
5.

Recent advances in optic neuritis related to multiple sclerosis.

Chan JW.

Acta Ophthalmol. 2012 May;90(3):203-9. doi: 10.1111/j.1755-3768.2011.02145.x. Epub 2011 Apr 12. Review.

6.

Optical coherence tomography in optic neuritis and multiple sclerosis: a review.

Kallenbach K, Frederiksen J.

Eur J Neurol. 2007 Aug;14(8):841-9. Review.

PMID:
17662003
7.

Optical coherence tomography detection of neurodegeneration in multiple sclerosis.

Lidster K, Baker D.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):518-27. Review.

PMID:
22583437
8.

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C.

Lancet Neurol. 2010 Sep;9(9):921-32. doi: 10.1016/S1474-4422(10)70168-X. Review. Erratum in: Lancet Neurol. 2010 Nov;9(11):1045.

PMID:
20723847
9.

Afferent visual pathways in multiple sclerosis: a review.

Graham SL, Klistorner A.

Clin Experiment Ophthalmol. 2016 Mar 24. doi: 10.1111/ceo.12751. [Epub ahead of print] Review.

PMID:
27011293
10.

Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials.

Galetta KM, Balcer LJ.

Mult Scler Relat Disord. 2013 Jul;2(3):172-82. doi: 10.1016/j.msard.2012.12.004. Epub 2013 Jan 30. Review.

PMID:
25877723
11.

The visual pathway as a model to understand brain damage in multiple sclerosis.

Martínez-Lapiscina EH, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe AI, Torres-Torres R, Villoslada P.

Mult Scler. 2014 Nov;20(13):1678-85. doi: 10.1177/1352458514542862. Epub 2014 Jul 10. Review.

PMID:
25013155
12.

A review of the anterior visual pathway model and the study of vitamin D in demyelinating disease.

Burton JM, Costello F.

Mult Scler Relat Disord. 2014 Jan;3(1):22-7. doi: 10.1016/j.msard.2013.06.013. Epub 2013 Jul 17. Review.

PMID:
25877968
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk